Skip to main content
logo
Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
12.18
+0.02 (0.16%)
At close: Aug 28, 2026, 4:00 PM EDT
12.35
+0.17 (1.40%)
After-hours: Aug 28, 2026, 7:56 PM EDT

Medifast Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-25.6-18.672.0999.42143.57164.03
Depreciation & Amortization
13.8514.2412.7113.1110.986.81
Loss (Gain) From Sale of Assets
-1.141.370.091.172.130
Loss (Gain) From Sale of Investments
-0.59-43.2-0.320.010.09
Stock-Based Compensation
6.87.647.368.1911.059.9
Other Operating Activities
16.0716.088.785.825.171.35
Change in Inventory
9.0222.1912.1764.2761.19-126.65
Change in Accounts Payable
-9.05-23.91-34.99-35.71-37.5954.38
Change in Income Taxes
-0.75-6.610.21-9.161.37-0.95
Change in Other Net Operating Assets
0.18-1.482.870.87-3.32-14.43
Operating Cash Flow
8.796.8624.48147.66194.5794.55
Operating Cash Flow Growth
111.70%-71.96%-83.42%-24.11%105.80%-34.88%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-4.78-5.61-7.45-6.48-16.68-34.21
Sale of Property, Plant & Equipment
3.64-----
Investment in Securities
-36.46-2.31-19.07-54.565.275.15
Investing Cash Flow
-37.6-7.93-26.52-61.05-11.41-29.06

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
--0.040.19-0.81
Repurchase of Common Stock
-0.81-0.37-0.84-6.96-127.96-62.09
Common Dividends Paid
-0.17-0.2-0.72-73.02-71.62-63.86
Financing Cash Flow
-0.98-0.56-1.52-79.79-199.58-125.13

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
000.05-0.07-0.070.11
Net Cash Flow
-29.78-1.63-3.516.75-16.49-59.54

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
4.011.2517.02141.17177.8960.34
Free Cash Flow Growth
--92.66%-87.94%-20.64%194.83%-56.69%
Free Cash Flow Margin
1.27%0.32%2.83%13.17%11.13%3.95%
Free Cash Flow Per Share
0.360.111.5512.9315.785.11
Levered Free Cash Flow
11.375.4115.72106.22154.4635.66
Unlevered Free Cash Flow
11.375.4115.72106.22154.8935.81

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
3.610.47-1.6234.2637.2156.76
Change in Working Capital
-0.59-9.81-9.7520.2821.65-87.65
SEC Filings: 10-K · 10-Q